Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D018357', 'term': 'Respiratory Syncytial Virus Infections'}], 'ancestors': [{'id': 'D018186', 'term': 'Pneumovirus Infections'}, {'id': 'D018184', 'term': 'Paramyxoviridae Infections'}, {'id': 'D018701', 'term': 'Mononegavirales Infections'}, {'id': 'D012327', 'term': 'RNA Virus Infections'}, {'id': 'D014777', 'term': 'Virus Diseases'}, {'id': 'D007239', 'term': 'Infections'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE3'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'PREVENTION', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'This is an extension and crossover study.'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 10212}}, 'statusModule': {'overallStatus': 'ACTIVE_NOT_RECRUITING', 'startDateStruct': {'date': '2024-08-01', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-12', 'completionDateStruct': {'date': '2026-09-30', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2025-12-19', 'studyFirstSubmitDate': '2024-07-30', 'studyFirstSubmitQcDate': '2024-07-30', 'lastUpdatePostDateStruct': {'date': '2025-12-22', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2024-08-02', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2026-09-30', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'RSV-A neutralizing titers expressed as Geometric mean titers (GMTs) in RSV_PreS4 group at Day 1', 'timeFrame': 'At Day 1'}, {'measure': 'RSV-A neutralizing titers expressed as GMTs in RSV_PreS4 group at Day 31', 'timeFrame': 'At Day 31'}, {'measure': 'RSV-B neutralizing titers expressed as GMTs in RSV_PreS4 group at Day 1', 'timeFrame': 'At Day 1'}, {'measure': 'RSV-B neutralizing titers expressed as GMTs in RSV_PreS4 group at Day 31', 'timeFrame': 'At Day 31'}, {'measure': 'RSV-A neutralizing titers expressed as Mean geometric increase (MGI) in RSV_PreS4 group', 'timeFrame': 'From Day 1 to Day 31'}, {'measure': 'RSV-B neutralizing titers expressed as MGI in RSV_PreS4 group', 'timeFrame': 'From Day 1 to Day 31'}, {'measure': 'Percentage of participants with RSV-A neutralizing titers greater than or equal to (>=) cut-off in RSV_PreS4 group at Day 1', 'timeFrame': 'At Day 1'}, {'measure': 'Percentage of participants with RSV-A neutralizing titers >= cut-off in RSV_PreS4 group at Day 31', 'timeFrame': 'At Day 31'}, {'measure': 'Percentage of participants with RSV-B neutralizing titers >=cut-off in RSV_PreS4 group at Day 1', 'timeFrame': 'At Day 1'}, {'measure': 'Percentage of participants with RSV-B neutralizing titers >=cut-off in RSV_PreS4 group at Day 31', 'timeFrame': 'At Day 31'}, {'measure': 'Percentage of participants with seroresponse rate (SRR) for RSV-A neutralizing titers in RSV_PreS4 group', 'timeFrame': 'At Day 31'}, {'measure': 'Percentage of participants with SRR for RSV-B neutralizing titers in RSV_PreS4 group', 'timeFrame': 'At Day 31'}, {'measure': 'RSV-A neutralizing titers expressed as GMT in RSV_PreS5 group at Day 1', 'timeFrame': 'At Day 1'}, {'measure': 'RSV-A neutralizing titers expressed as GMT in RSV_PreS5 group at Month 12', 'timeFrame': 'At Month 12'}, {'measure': 'RSV-A neutralizing titers expressed as GMT in RSV_PreS5 group at Month 13', 'timeFrame': 'At Month 13'}, {'measure': 'RSV-A neutralizing titers expressed as GMT in RSV_PreS5 group at Month 24', 'timeFrame': 'At Month 24'}, {'measure': 'RSV-B neutralizing titers expressed as GMTs in RSV_PreS5 group at Day 1', 'timeFrame': 'At Day 1'}, {'measure': 'RSV-B neutralizing titers expressed as GMTs in RSV_PreS5 group at Month 12', 'timeFrame': 'At Month 12'}, {'measure': 'RSV-B neutralizing titers expressed as GMTs in RSV_PreS5 group at Month 13', 'timeFrame': 'At Month 13'}, {'measure': 'RSV-B neutralizing titers expressed as GMTs in RSV_PreS5 group at Month 24', 'timeFrame': 'At Month 24'}, {'measure': 'RSV-A neutralizing titers expressed as MGI in RSV_PreS5 group from Month 12 to Month 13', 'timeFrame': 'From Month 12 to Month 13'}, {'measure': 'RSV-A neutralizing titers expressed as MGI in RSV_PreS5 group from Month 12 to Month 24', 'timeFrame': 'From Month 12 to Month 24'}, {'measure': 'RSV-B neutralizing titers expressed as MGI in RSV_PreS5 group from Month 12 to Month 13', 'timeFrame': 'From Month 12 to Month 13'}, {'measure': 'RSV-B neutralizing titers expressed as MGI in RSV_PreS5 group from Month 12 to Month 24', 'timeFrame': 'From Month 12 to Month 24'}, {'measure': 'Percentage of participants with RSV-A neutralizing titers >=cut-off in RSV_PreS5 group at Day 1', 'timeFrame': 'At Day 1'}, {'measure': 'Percentage of participants with RSV-A neutralizing titers >=cut-off in RSV_PreS5 group at Month 12', 'timeFrame': 'At Month 12'}, {'measure': 'Percentage of participants with RSV-A neutralizing titers >=cut-off in RSV_PreS5 group at Month 13', 'timeFrame': 'At Month 13'}, {'measure': 'Percentage of participants with RSV-A neutralizing titers >=cut-off in RSV_PreS5 group at Month 24', 'timeFrame': 'At Month 24'}, {'measure': 'Percentage of participants with RSV-B neutralizing titers >=cut-off in RSV_PreS5 group at Day 1', 'timeFrame': 'At Day 1'}, {'measure': 'Percentage of participants with RSV-B neutralizing titers >=cut-off in RSV_PreS5 group at Month 12', 'timeFrame': 'At Month 12'}, {'measure': 'Percentage of participants with RSV-B neutralizing titers >=cut-off in RSV_PreS5 group at Month 13', 'timeFrame': 'At Month 13'}, {'measure': 'Percentage of participants with RSV-B neutralizing titers >=cut-off in RSV_PreS5 group at Month 24', 'timeFrame': 'At Month 24'}, {'measure': 'Percentage of participants with seroresponse rate (SRR) for RSV-A neutralizing titers in RSV_PreS5 group', 'timeFrame': 'At Month 13'}, {'measure': 'Percentage of participants with SRR for RSV-B neutralizing titers in RSV_PreS5 group', 'timeFrame': 'At Month 13'}], 'secondaryOutcomes': [{'measure': 'RSV-A neutralizing titers expressed as GMTs in RSV_1Dose group', 'timeFrame': 'At Day 1, Month 12 and at Month 24'}, {'measure': 'RSV-B neutralizing titers expressed as GMTs in RSV_1Dose group', 'timeFrame': 'At Day 1, Month 12 and at Month 24'}, {'measure': 'Percentage of participants with RSV-A neutralizing titers >= cut-off in RSV_1Dose group', 'timeFrame': 'At Day 1, Month 12 and at Month 24'}, {'measure': 'Percentage of participants with RSV-B neutralizing titers >= cut-off in RSV_1Dose group', 'timeFrame': 'At Day 1, Month 12 and at Month 24'}, {'measure': 'Number of participants with unsolicited adverse events', 'timeFrame': 'At Day 30 post vaccination'}, {'measure': 'Number of participants with any serious adverse events (SAEs)', 'timeFrame': 'From day of vaccination and up to 6 months post each vaccine administration'}, {'measure': 'Number of participants with SAEs related to study intervention', 'timeFrame': 'From Day 1 and up to end of study'}, {'measure': 'Number of participants with any potential immune-mediated disease (pIMDs)', 'timeFrame': 'From day of vaccination and up to 6 months post each vaccine administration'}, {'measure': 'Number of participants with pIMDs related to study intervention', 'timeFrame': 'From Day 1 and up to end of study'}, {'measure': 'Number of participants with fatal SAEs', 'timeFrame': 'From Day 1 and up to end of study'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': True, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['Respiratory syncytial virus (RSV)', 'Older adults', 'RSVPreF3 OA vaccine', 'Immunogenicity', 'Safety', 'RSV Season'], 'conditions': ['Respiratory Syncytial Virus Infections']}, 'descriptionModule': {'briefSummary': 'The purpose of this study is:\n\n* To investigate the optimal timing for revaccination after the initial RSVPreF3 OA vaccine dose,\n* To evaluate the long-term immune persistence and safety up to 5 consecutive RSV seasons (approximately 60 months) of a single dose of RSVPreF3 OA vaccine,\n* To give the opportunity to participants who received only placebo in the RSVOA=ADJ- 006 study, to receive a dose of the RSVPreF3 OA vaccine and collect additional safety information.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '60 Years', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Male or female participants who were previously enrolled in the RSV OA=ADJ-006 study and received placebo (Placebo group) or a single dose of the RSVPreF3 OA vaccine (RSV\\_1dose group).\n* Participants who, in the opinion of the investigator, can and will comply with the requirements of the protocol (e.g. completion of the diary cards, attend regular phone calls/study site visits, ability to access and utilize a phone or other electronic communications).\n* Written or witnessed informed consent obtained from the participant prior to performance of any study specific procedure.\n* Participants who are medically stable in the opinion of the investigator at study entry. Participants with chronic stable medical conditions with or without specific treatment, such as diabetes, hypertension or cardiac disease, are allowed to participate in this study.\n\nExclusion Criteria:\n\nMedical Conditions:\n\n* Any confirmed or suspected immunosuppressive or immunodeficient condition resulting from disease or immunosuppressive/cytotoxic therapy based on medical history and physical examination.\n* History of any reaction or hypersensitivity likely to be exacerbated by any component of the study intervention.\n* Hypersensitivity to latex.\n* Serious or unstable chronic illness.\n* Recurrent or un-controlled neurological disorders or seizures.\n* Significant underlying illness that in the opinion of the investigator would be expected to prevent completion of the study.\n* Any other medical condition that in the judgment of the investigator would make intramuscular injection unsafe.\n* Any other clinical condition that, in the opinion of the investigator, might pose additional risk to the participant due to participation in the study.\n* Any history of dementia or any medical condition that moderately or severely impairs cognition and understanding of the informed consent form and/or study procedures.\n* Participants who experienced an SAE or pIMD from first study intervention administration in the RSV OA=ADJ-006 study until enrollment in this study that was considered to be possibly or probably related to the study vaccine or non-study concomitant vaccines, either by the investigator or the sponsor, including hypersensitivity reactions.\n* Participants with a new onset of a pIMD or exacerbation of a pIMD from first study intervention administration in the RSV OA=ADJ-006 study until enrollment in this study, that, in the opinion of the investigator, exposes the participant to unacceptable risk from subsequent vaccination.\n\nPrior/Concomitant Therapy:\n\n• Use of any investigational or non-registered product other than the study vaccine during the period beginning 30 days before the first dose of study vaccine, or planned use during the study period. • Previous vaccination with an RSV vaccine (investigational or licensed vaccine) and/or planned administration of an RSV vaccine during the study period other than the RSVPreF3 OA vaccine administered during the RSV OA=ADJ-006 study.\n\nPrior/Concurrent Clinical Study Experience:\n\n• Concurrently participating in another clinical study, at any time during the study period, in which the participant has been or will be exposed to an investigational or a non-investigational vaccine/product.\n\nOther Exclusion Criteria:\n\n* History of chronic alcohol consumption and/or drug abuse as deemed by the investigator to render the potential participant unable/unlikely to provide accurate safety reports or comply with study procedures.\n* Participation of any study personnel or their immediate dependents, family, or household members.\n* Bedridden participants.\n\nSpecific exclusion criteria for Crossover group:\n\n• Planned or administration of a vaccine not foreseen by the study protocol in the period starting 30 days before and ending 30 days after study intervention administration, with the exception of COVID vaccines which can be administered up to 14 days before or from 14 days after study vaccination. Inactivated seasonal influenza vaccines can be co-administered or administered at any time.\n\nSpecific exclusion criteria for RSV\\_PreS4, RSV\\_PreS5 and RSV\\_1Dose groups:\n\n* Planned or administration of a vaccine not foreseen by the study protocol in the period starting 30 days before and ending 30 days after study intervention administration, with the exception of COVID vaccines and inactivated seasonal influenza vaccines which can be administered up to 14 days before or from 14 days after study intervention administration.\n* Administration of long-acting immune-modifying drugs or planned administration at any time during the study period.\n* Administration of immunoglobulins and/or any blood products or plasma derivatives during the period starting 90 days before the first study visit or planned administration during the study period.\n* Chronic administration of immunosuppressants or other immunemodifying drugs during the period starting 90 days prior to the first study visit or planned administration during the study period. For corticosteroids, this will mean prednisone \\>= 20 mg/day, or equivalent. Inhaled and topical steroids are allowed.'}, 'identificationModule': {'nctId': 'NCT06534892', 'acronym': 'RSV OA=ADJ=012', 'briefTitle': 'An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study', 'organization': {'class': 'INDUSTRY', 'fullName': 'GlaxoSmithKline'}, 'officialTitle': 'A Phase 3b, Randomized, Open Label, Multicountry, Multi-center, Extension and Crossover Vaccination Study to Evaluate the Immunogenicity and Safety of Different Revaccination Schedules and Persistence of a Single Dose of the RSVPreF3 OA Vaccine in Adults Aged 60 Years and Above Who Participated in the RSV OA=ADJ-006 Study', 'orgStudyIdInfo': {'id': '222090'}, 'secondaryIdInfos': [{'id': '2023-509762-38-00', 'type': 'OTHER', 'domain': 'EU CTR Number'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'RSV_PreS4', 'description': 'Participants in this group will receive 1 dose of RSVPreF3 OA vaccine before RSV Season 4.', 'interventionNames': ['Biological: RSVPreF3 OA vaccine']}, {'type': 'EXPERIMENTAL', 'label': 'RSV_PreS5', 'description': 'Participants in this group will receive 1 dose of RSVPreF3 OA vaccine before RSV Season 5.', 'interventionNames': ['Biological: RSVPreF3 OA vaccine']}, {'type': 'NO_INTERVENTION', 'label': 'RSV_1Dose', 'description': 'Participants in this group will not receive any additional dose of RSV PreF3 OA vaccine.'}, {'type': 'EXPERIMENTAL', 'label': 'Crossover', 'description': 'Participants in this group will receive a single dose of RSVPreF3 OA vaccine.', 'interventionNames': ['Biological: RSVPreF3 OA vaccine']}], 'interventions': [{'name': 'RSVPreF3 OA vaccine', 'type': 'BIOLOGICAL', 'description': 'RSVPreF3 OA vaccine administered at different timepoints (revaccination groups) or for the first time (crossover group)', 'armGroupLabels': ['Crossover', 'RSV_PreS4', 'RSV_PreS5']}]}, 'contactsLocationsModule': {'locations': [{'zip': '35205', 'city': 'Birmingham', 'state': 'Alabama', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 33.52066, 'lon': -86.80249}}, {'zip': '35211', 'city': 'Birmingham', 'state': 'Alabama', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 33.52066, 'lon': -86.80249}}, {'zip': '35802', 'city': 'Huntsville', 'state': 'Alabama', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 34.7304, 'lon': -86.58594}}, {'zip': '85020', 'city': 'Phoenix', 'state': 'Arizona', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 33.44838, 'lon': -112.07404}}, {'zip': '85741', 'city': 'Tucson', 'state': 'Arizona', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.22174, 'lon': -110.92648}}, {'zip': '90703', 'city': 'Cerritos', 'state': 'California', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 33.85835, 'lon': -118.06479}}, {'zip': '33172', 'city': 'Doral', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 25.81954, 'lon': -80.35533}}, {'zip': '33912', 'city': 'Fort Myers', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 26.62168, 'lon': -81.84059}}, {'zip': '32205', 'city': 'Jacksonville', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 30.33218, 'lon': -81.65565}}, {'zip': '32055', 'city': 'Lake City', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 30.18968, 'lon': -82.63929}}, {'zip': '32934', 'city': 'Melbourne', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 28.08363, 'lon': -80.60811}}, {'zip': '33174', 'city': 'Miami', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 25.77427, 'lon': -80.19366}}, {'zip': '32806', 'city': 'Orlando', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 28.53834, 'lon': -81.37924}}, {'zip': '33781', 'city': 'Pinellas Park', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 27.8428, 'lon': -82.69954}}, {'zip': '32162', 'city': 'The Villages', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 28.93408, 'lon': -81.95994}}, {'zip': '33409', 'city': 'West Palm Beach', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 26.71534, 'lon': -80.05337}}, {'zip': '30328', 'city': 'Atlanta', 'state': 'Georgia', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 33.749, 'lon': -84.38798}}, {'zip': '31406', 'city': 'Savannah', 'state': 'Georgia', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.08354, 'lon': -81.09983}}, {'zip': '60602', 'city': 'Chicago', 'state': 'Illinois', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.85003, 'lon': -87.65005}}, {'zip': '47714', 'city': 'Evansville', 'state': 'Indiana', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.97476, 'lon': -87.55585}}, {'zip': '46544', 'city': 'Mishawaka', 'state': 'Indiana', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.66199, 'lon': -86.15862}}, {'zip': '67042', 'city': 'El Dorado', 'state': 'Kansas', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.81724, 'lon': -96.86225}}, {'zip': '67114', 'city': 'Newton', 'state': 'Kansas', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 38.04668, 'lon': -97.34504}}, {'zip': '67205', 'city': 'Wichita', 'state': 'Kansas', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.69224, 'lon': -97.33754}}, {'zip': '67207', 'city': 'Wichita', 'state': 'Kansas', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.69224, 'lon': -97.33754}}, {'zip': '40509', 'city': 'Lexington', 'state': 'Kentucky', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.98869, 'lon': -84.47772}}, {'zip': '20854', 'city': 'Rockville', 'state': 'Maryland', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 39.084, 'lon': -77.15276}}, {'zip': '55423', 'city': 'Richfield', 'state': 'Minnesota', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 44.8833, 'lon': -93.283}}, {'zip': '64114', 'city': 'Kansas City', 'state': 'Missouri', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 39.09973, 'lon': -94.57857}}, {'zip': '63141', 'city': 'St Louis', 'state': 'Missouri', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 38.62727, 'lon': -90.19789}}, {'zip': '68134', 'city': 'Omaha', 'state': 'Nebraska', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.25626, 'lon': -95.94043}}, {'zip': '89113', 'city': 'Las Vegas', 'state': 'Nevada', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 36.17497, 'lon': -115.13722}}, {'zip': '10017', 'city': 'New York', 'state': 'New York', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '14609', 'city': 'Rochester', 'state': 'New York', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.15478, 'lon': -77.61556}}, {'zip': '28601', 'city': 'Hickory', 'state': 'North Carolina', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.73319, 'lon': -81.3412}}, {'zip': '28117', 'city': 'Mooresville', 'state': 'North Carolina', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.58486, 'lon': -80.81007}}, {'zip': '27804', 'city': 'Rocky Mount', 'state': 'North Carolina', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.93821, 'lon': -77.79053}}, {'zip': '28144', 'city': 'Salisbury', 'state': 'North Carolina', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.67097, 'lon': -80.47423}}, {'zip': '27103', 'city': 'Winston-Salem', 'state': 'North Carolina', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 36.09986, 'lon': -80.24422}}, {'zip': '45459', 'city': 'Centerville', 'state': 'Ohio', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 39.62839, 'lon': -84.15938}}, {'zip': '45236', 'city': 'Cincinnati', 'state': 'Ohio', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 39.12711, 'lon': -84.51439}}, {'zip': '43212', 'city': 'Columbus', 'state': 'Ohio', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 39.96118, 'lon': -82.99879}}, {'zip': '16508', 'city': 'Erie', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 42.12922, 'lon': -80.08506}}, {'zip': '15236', 'city': 'Pittsburgh', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.44062, 'lon': -79.99589}}, {'zip': '29621', 'city': 'Anderson', 'state': 'South Carolina', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 34.50344, 'lon': -82.65013}}, {'zip': '29405', 'city': 'Mt. Pleasant', 'state': 'South Carolina', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.79407, 'lon': -79.86259}}, {'zip': '37938', 'city': 'Knoxville', 'state': 'Tennessee', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.96064, 'lon': -83.92074}}, {'zip': '38119', 'city': 'Memphis', 'state': 'Tennessee', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.14953, 'lon': -90.04898}}, {'zip': '75234', 'city': 'Dallas', 'state': 'Texas', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.78306, 'lon': -96.80667}}, {'zip': '76104', 'city': 'Fort Worth', 'state': 'Texas', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.72541, 'lon': -97.32085}}, {'zip': '77008', 'city': 'Houston', 'state': 'Texas', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 29.76328, 'lon': -95.36327}}, {'zip': '76248', 'city': 'Keller', 'state': 'Texas', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.93457, 'lon': -97.25168}}, {'zip': '78229', 'city': 'San Antonio', 'state': 'Texas', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 29.42412, 'lon': -98.49363}}, {'zip': '84106', 'city': 'Salt Lake City', 'state': 'Utah', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.76078, 'lon': -111.89105}}, {'zip': '23502', 'city': 'Norfolk', 'state': 'Virginia', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 36.84681, 'lon': -76.28522}}, {'zip': '2019', 'city': 'Botany', 'state': 'New South Wales', 'country': 'Australia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -33.94599, 'lon': 151.19591}}, {'zip': '2450', 'city': 'Coffs Harbour', 'state': 'New South Wales', 'country': 'Australia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -30.29626, 'lon': 153.11351}}, {'zip': '2010', 'city': 'Sydney', 'state': 'New South Wales', 'country': 'Australia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -33.86785, 'lon': 151.20732}}, {'zip': '4068', 'city': 'Taringa', 'state': 'Queensland', 'country': 'Australia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -27.49061, 'lon': 152.97861}}, {'zip': '4121', 'city': 'Tarragindi', 'state': 'Queensland', 'country': 'Australia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -27.52713, 'lon': 153.04556}}, {'zip': '3124', 'city': 'Camberwell', 'state': 'Victoria', 'country': 'Australia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -37.84205, 'lon': 145.0694}}, {'zip': '3220', 'city': 'Geelong', 'state': 'Victoria', 'country': 'Australia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -38.14711, 'lon': 144.36069}}, {'zip': '6163', 'city': 'Spearwood', 'state': 'Western Australia', 'country': 'Australia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -32.10534, 'lon': 115.77797}}, {'zip': '3590', 'city': 'Diepenbeek', 'country': 'Belgium', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.90769, 'lon': 5.41875}}, {'zip': '2650', 'city': 'Edegem', 'country': 'Belgium', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.15662, 'lon': 4.44504}}, {'zip': '5101', 'city': 'Erpent', 'country': 'Belgium', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.45116, 'lon': 4.90557}}, {'zip': '3600', 'city': 'Genk', 'country': 'Belgium', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.965, 'lon': 5.50082}}, {'zip': '9000', 'city': 'Ghent', 'country': 'Belgium', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.05, 'lon': 3.71667}}, {'zip': '8900', 'city': 'Ieper', 'country': 'Belgium', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.85114, 'lon': 2.88569}}, {'zip': '9690', 'city': 'Kluisbergen', 'country': 'Belgium', 'facility': 'GSK Investigational Site'}, {'zip': '3545', 'city': 'Linkebeek', 'country': 'Belgium', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.76781, 'lon': 4.33688}}, {'zip': '6534', 'city': 'Linkebeek', 'country': 'Belgium', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.76781, 'lon': 4.33688}}, {'zip': '2800', 'city': 'Mechelen', 'country': 'Belgium', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.02574, 'lon': 4.47762}}, {'zip': '3120', 'city': 'Tremelo', 'country': 'Belgium', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.99231, 'lon': 4.70807}}, {'zip': 'T5A 4L8', 'city': 'Edmonton', 'state': 'Alberta', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 53.55014, 'lon': -113.46871}}, {'zip': 'V3L 3W4', 'city': 'New Westminster', 'state': 'British Columbia', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 49.20678, 'lon': -122.91092}}, {'zip': 'V3S 2N6', 'city': 'Surrey', 'state': 'British Columbia', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 49.10635, 'lon': -122.82509}}, {'zip': 'V6Z 2T1', 'city': 'Vancouver', 'state': 'British Columbia', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 49.24966, 'lon': -123.11934}}, {'zip': 'V8V 3M9', 'city': 'Victoria', 'state': 'British Columbia', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.4359, 'lon': -123.35155}}, {'zip': 'V8V 4A1', 'city': 'Victoria', 'state': 'British Columbia', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.4359, 'lon': -123.35155}}, {'zip': 'B3J 3G9', 'city': 'Halifax', 'state': 'Nova Scotia', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 44.64269, 'lon': -63.57688}}, {'zip': 'B2N 1L2', 'city': 'Truro', 'state': 'Nova Scotia', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.36685, 'lon': -63.26538}}, {'zip': 'P3C 1X3', 'city': 'Greater Sudbury', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 46.49, 'lon': -80.99001}}, {'zip': 'N5W 6A2', 'city': 'London-Ontario', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site'}, {'zip': 'K1H 8L6', 'city': 'Ottawa', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.41117, 'lon': -75.69812}}, {'zip': 'N7T 4X3', 'city': 'Sarnia', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 42.97866, 'lon': -82.40407}}, {'zip': 'M9W 4L6', 'city': 'Toronto', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.70643, 'lon': -79.39864}}, {'zip': 'G7H 7Y8', 'city': 'Chicoutimi', 'state': 'Quebec', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.41963, 'lon': -71.06369}}, {'zip': 'J7J 2K8', 'city': 'Mirabel', 'state': 'Quebec', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.65008, 'lon': -74.08251}}, {'zip': 'H9R4S3', 'city': 'Pointe-Claire', 'state': 'Quebec', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.44868, 'lon': -73.81669}}, {'zip': 'G1W 4R4', 'city': 'Québec', 'state': 'Quebec', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 46.81228, 'lon': -71.21454}}, {'zip': 'J6E 2B4', 'city': 'Saint-Charles-Borromée', 'state': 'Quebec', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 46.05007, 'lon': -73.46586}}, {'zip': 'G1E 7G9', 'city': 'Sainte-Foy', 'state': 'Quebec', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 46.78139, 'lon': -71.29217}}, {'zip': 'J1J 2G2', 'city': 'Sherbrooke', 'state': 'Quebec', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.40008, 'lon': -71.89908}}, {'zip': '72713', 'city': 'Paide', 'country': 'Estonia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 58.88768, 'lon': 25.54042}}, {'zip': '10117', 'city': 'Tallinn', 'country': 'Estonia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 59.43696, 'lon': 24.75353}}, {'zip': '10128', 'city': 'Tallinn', 'country': 'Estonia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 59.43696, 'lon': 24.75353}}, {'zip': '10617', 'city': 'Tallinn', 'country': 'Estonia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 59.43696, 'lon': 24.75353}}, {'zip': '13619', 'city': 'Tallinn', 'country': 'Estonia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 59.43696, 'lon': 24.75353}}, {'zip': '51014', 'city': 'Tartu', 'country': 'Estonia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 58.38062, 'lon': 26.72509}}, {'zip': '02230', 'city': 'Espoo', 'country': 'Finland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 60.2052, 'lon': 24.6522}}, {'zip': '00100', 'city': 'Helsinki', 'country': 'Finland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 60.16952, 'lon': 24.93545}}, {'zip': '00930', 'city': 'Helsinki', 'country': 'Finland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 60.16952, 'lon': 24.93545}}, {'zip': '04400', 'city': 'Järvenpää', 'country': 'Finland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 60.47369, 'lon': 25.08992}}, {'zip': '67100', 'city': 'Kokkola', 'country': 'Finland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 63.83847, 'lon': 23.13066}}, {'zip': '90220', 'city': 'Oulu', 'country': 'Finland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 65.01236, 'lon': 25.46816}}, {'zip': '60100', 'city': 'Seinäjoki', 'country': 'Finland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 62.79446, 'lon': 22.82822}}, {'zip': '33100', 'city': 'Tampere', 'country': 'Finland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 61.49911, 'lon': 23.78712}}, {'zip': '20520', 'city': 'Turku', 'country': 'Finland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 60.45148, 'lon': 22.26869}}, {'zip': '69469', 'city': 'Weinheim', 'state': 'Baden-Wurttemberg', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 49.54887, 'lon': 8.66697}}, {'zip': '80339', 'city': 'Munich', 'state': 'Bavaria', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.13743, 'lon': 11.57549}}, {'zip': '09599', 'city': 'Freiberg', 'state': 'Saxony', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.91089, 'lon': 13.33881}}, {'zip': '10117', 'city': 'Berlin', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '12627', 'city': 'Berlin', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '13347', 'city': 'Berlin', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '51069', 'city': 'Cologne', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.93333, 'lon': 6.95}}, {'zip': '85221', 'city': 'Dachau', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.26, 'lon': 11.43402}}, {'zip': '01744', 'city': 'Dippoldiswalde', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.89621, 'lon': 13.66905}}, {'zip': '01279', 'city': 'Dresden', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.05089, 'lon': 13.73832}}, {'zip': '45355', 'city': 'Essen', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.45657, 'lon': 7.01228}}, {'zip': '45359', 'city': 'Essen', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.45657, 'lon': 7.01228}}, {'zip': '60313', 'city': 'Frankfurt', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 49.68333, 'lon': 10.53333}}, {'zip': '01705', 'city': 'Freital', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.00166, 'lon': 13.6488}}, {'zip': '47574', 'city': 'Goch', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.67873, 'lon': 6.15895}}, {'zip': '20095', 'city': 'Hamburg', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 53.55073, 'lon': 9.99302}}, {'zip': '22143', 'city': 'Hamburg', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 53.55073, 'lon': 9.99302}}, {'zip': '30159', 'city': 'Hanover', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.37052, 'lon': 9.73322}}, {'zip': '65239', 'city': 'Hochheim am Main', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.01436, 'lon': 8.35218}}, {'zip': '04103', 'city': 'Leipzig', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.33962, 'lon': 12.37129}}, {'zip': '55116', 'city': 'Mainz', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 49.98185, 'lon': 8.28008}}, {'zip': '22869', 'city': 'Schenefeld', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 54.04644, 'lon': 9.48146}}, {'zip': '94574', 'city': 'Wallerfing', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.68416, 'lon': 12.88035}}, {'zip': '88239', 'city': 'Wangen', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.6895, 'lon': 9.83247}}, {'zip': '58455', 'city': 'Witten', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.44362, 'lon': 7.35258}}, {'zip': '97070', 'city': 'Würzburg', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 49.79391, 'lon': 9.95121}}, {'zip': '15121', 'city': 'Alessandria', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 44.90924, 'lon': 8.61007}}, {'zip': '70124', 'city': 'Bari', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.12066, 'lon': 16.86982}}, {'zip': '32100', 'city': 'Belluno', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 46.14262, 'lon': 12.2156}}, {'zip': '44124', 'city': 'Ferrara', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 44.83804, 'lon': 11.62057}}, {'zip': '80131', 'city': 'Napoli', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.87618, 'lon': 14.5195}}, {'zip': '37024', 'city': 'Negrar Verona', 'country': 'Italy', 'facility': 'GSK Investigational Site'}, {'zip': '90127', 'city': 'Palermo', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 38.1166, 'lon': 13.3636}}, {'zip': '10023', 'city': 'Pessione - Chieri to', 'country': 'Italy', 'facility': 'GSK Investigational Site'}, {'zip': '56126', 'city': 'Pisa', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.70853, 'lon': 10.4036}}, {'zip': '00128', 'city': 'Roma', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 44.99364, 'lon': 11.10642}}, {'zip': '53100', 'city': 'Siena', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.31822, 'lon': 11.33064}}, {'zip': '732-0053', 'city': 'Hiroshima', 'country': 'Japan', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 34.4, 'lon': 132.45}}, {'zip': '306-0041', 'city': 'Ibaraki', 'country': 'Japan', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 34.81641, 'lon': 135.56828}}, {'zip': '860-0863', 'city': 'Kumamoto', 'country': 'Japan', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.80589, 'lon': 130.69181}}, {'zip': '901-2393', 'city': 'Okinawa', 'country': 'Japan', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 26.33583, 'lon': 127.80139}}, {'zip': '350-1122', 'city': 'Saitama', 'country': 'Japan', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.90807, 'lon': 139.65657}}, {'zip': '421-0193', 'city': 'Shizuoka', 'country': 'Japan', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 34.98333, 'lon': 138.38333}}, {'zip': '121-0815', 'city': 'Tokyo', 'country': 'Japan', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.6895, 'lon': 139.69171}}, {'zip': '160-0017', 'city': 'Tokyo', 'country': 'Japan', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.6895, 'lon': 139.69171}}, {'zip': '165-0031', 'city': 'Tokyo', 'country': 'Japan', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.6895, 'lon': 139.69171}}, {'zip': '169-0072', 'city': 'Tokyo', 'country': 'Japan', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.6895, 'lon': 139.69171}}, {'zip': '990-0834', 'city': 'Yamagata', 'country': 'Japan', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 38.23333, 'lon': 140.36667}}, {'zip': '750-0061', 'city': 'Yamaguchi', 'country': 'Japan', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 34.18333, 'lon': 131.46667}}, {'zip': '31203', 'city': 'Chihuahua City', 'country': 'Mexico', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 28.63528, 'lon': -106.08889}}, {'zip': '37530', 'city': 'León', 'country': 'Mexico', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 25.60187, 'lon': -103.47698}}, {'zip': '06760', 'city': 'Mexico City', 'country': 'Mexico', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 19.42847, 'lon': -99.12766}}, {'zip': '97070', 'city': 'Mérida', 'country': 'Mexico', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 20.967, 'lon': -89.62318}}, {'zip': '64460', 'city': 'Monterrey', 'country': 'Mexico', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 25.68435, 'lon': -100.31721}}, {'zip': '68000', 'city': 'Oaxaca City', 'country': 'Mexico', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 17.06025, 'lon': -96.72544}}, {'zip': '76070', 'city': 'Querétaro', 'country': 'Mexico', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 15.83752, 'lon': -92.75774}}, {'zip': '03100', 'city': 'RM Pharmamexico CITY', 'country': 'Mexico', 'facility': 'GSK Investigational Site'}, {'zip': '78209', 'city': 'San Luis Potosí City', 'country': 'Mexico', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 22.15234, 'lon': -100.97135}}, {'zip': '1010', 'city': 'Grafton Auckland', 'country': 'New Zealand', 'facility': 'GSK Investigational Site'}, {'zip': '4122', 'city': "Hawke's Bay", 'country': 'New Zealand', 'facility': 'GSK Investigational Site'}, {'zip': '5032', 'city': 'Kapiti', 'country': 'New Zealand', 'facility': 'GSK Investigational Site'}, {'zip': '4414', 'city': 'Palmerston North', 'country': 'New Zealand', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -40.35636, 'lon': 175.61113}}, {'zip': '3110', 'city': 'Tauranga', 'country': 'New Zealand', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -37.68611, 'lon': 176.16667}}, {'zip': '6021', 'city': 'Wellington', 'country': 'New Zealand', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -41.28664, 'lon': 174.77557}}, {'zip': '42-202', 'city': 'Częstochowa', 'country': 'Poland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.79646, 'lon': 19.12409}}, {'zip': '82-300', 'city': 'Elblag', 'country': 'Poland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 54.1522, 'lon': 19.40884}}, {'zip': '80-382', 'city': 'Gdansk', 'country': 'Poland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 54.35227, 'lon': 18.64912}}, {'zip': '81-537', 'city': 'Gdynia', 'country': 'Poland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 54.51889, 'lon': 18.53188}}, {'zip': '40-040', 'city': 'Katowice', 'country': 'Poland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.2597, 'lon': 19.02173}}, {'zip': '40-282', 'city': 'Katowice', 'country': 'Poland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.2597, 'lon': 19.02173}}, {'zip': '40-648', 'city': 'Katowice', 'country': 'Poland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.2597, 'lon': 19.02173}}, {'zip': '31-501', 'city': 'Krakow', 'country': 'Poland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.06143, 'lon': 19.93658}}, {'zip': '90-127', 'city': 'Lodz', 'country': 'Poland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.77058, 'lon': 19.47395}}, {'zip': '91-363', 'city': 'Lodz', 'country': 'Poland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.77058, 'lon': 19.47395}}, {'zip': '60-702', 'city': 'Poznan', 'country': 'Poland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.40692, 'lon': 16.92993}}, {'zip': '02-672', 'city': 'Warsaw', 'country': 'Poland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.22977, 'lon': 21.01178}}, {'zip': '03-291', 'city': 'Warsaw', 'country': 'Poland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.22977, 'lon': 21.01178}}, {'zip': '50-088', 'city': 'Wroclaw', 'country': 'Poland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.10286, 'lon': 17.03006}}, {'zip': '53-671', 'city': 'Wroclaw', 'country': 'Poland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.10286, 'lon': 17.03006}}, {'zip': '188300', 'city': 'Gatchina', 'state': "Leningradskaya Oblast'", 'country': 'Russia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 59.57639, 'lon': 30.12833}}, {'zip': '656043', 'city': 'Barnaul', 'country': 'Russia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 53.36199, 'lon': 83.72786}}, {'zip': '650066', 'city': 'Kemerovo', 'country': 'Russia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 55.35417, 'lon': 86.10435}}, {'zip': '115478', 'city': 'Moscow', 'country': 'Russia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 55.75204, 'lon': 37.61781}}, {'zip': '196158', 'city': 'Saint Petersburg', 'country': 'Russia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 59.93863, 'lon': 30.31413}}, {'zip': '197022', 'city': 'Saint Petersburg', 'country': 'Russia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 59.93863, 'lon': 30.31413}}, {'zip': '191119', 'city': 'StPetersburg', 'country': 'Russia', 'facility': 'GSK Investigational Site'}, {'zip': '196143', 'city': 'StPetersburg', 'country': 'Russia', 'facility': 'GSK Investigational Site'}, {'zip': '620137', 'city': 'Yekaterinburg', 'country': 'Russia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 56.85733, 'lon': 60.61529}}, {'zip': '9300', 'city': 'Bloemfontein', 'country': 'South Africa', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -29.12107, 'lon': 26.214}}, {'zip': '7700', 'city': 'Cape Town', 'country': 'South Africa', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -33.92584, 'lon': 18.42322}}, {'zip': '1818', 'city': 'Johannesburg', 'country': 'South Africa', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -26.20227, 'lon': 28.04363}}, {'zip': '2113', 'city': 'Johannesburg', 'country': 'South Africa', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -26.20227, 'lon': 28.04363}}, {'zip': '1050', 'city': 'Middelburg', 'country': 'South Africa', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -25.77507, 'lon': 29.46482}}, {'zip': '1022', 'city': 'Moloto South', 'country': 'South Africa', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -25.46279, 'lon': 28.65041}}, {'zip': '1459', 'city': 'Reiger Park', 'country': 'South Africa', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -26.23226, 'lon': 28.21843}}, {'zip': '1632', 'city': 'Tembisa', 'country': 'South Africa', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -26.00979, 'lon': 28.22762}}, {'zip': '15355', 'city': 'Ansan', 'country': 'South Korea', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 36.8741, 'lon': 126.2116}}, {'zip': '14584', 'city': 'Bucheon-si Kyunggi-do 14584', 'country': 'South Korea', 'facility': 'GSK Investigational Site'}, {'zip': '41944', 'city': 'Daegu', 'country': 'South Korea', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.87028, 'lon': 128.59111}}, {'zip': '400-711', 'city': 'Incheon', 'country': 'South Korea', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.45646, 'lon': 126.70515}}, {'zip': '54907', 'city': 'Jeonju', 'country': 'South Korea', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.82194, 'lon': 127.14889}}, {'zip': '26426', 'city': 'Kangwon-do', 'country': 'South Korea', 'facility': 'GSK Investigational Site'}, {'zip': '06351', 'city': 'Seoul', 'country': 'South Korea', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.566, 'lon': 126.9784}}, {'zip': '07441', 'city': 'Seoul', 'country': 'South Korea', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.566, 'lon': 126.9784}}, {'zip': '08308', 'city': 'Seoul', 'country': 'South Korea', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.566, 'lon': 126.9784}}, {'zip': '135-720', 'city': 'Seoul', 'country': 'South Korea', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.566, 'lon': 126.9784}}, {'zip': '137-701', 'city': 'Seoul', 'country': 'South Korea', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.566, 'lon': 126.9784}}, {'zip': '442-723', 'city': 'Suwon Gyeonggi-do', 'country': 'South Korea', 'facility': 'GSK Investigational Site'}, {'zip': '28922', 'city': 'Alcorcón', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.34582, 'lon': -3.82487}}, {'zip': '08023', 'city': 'Barcelona', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.38879, 'lon': 2.15899}}, {'zip': '08036', 'city': 'Barcelona', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.38879, 'lon': 2.15899}}, {'zip': '08430', 'city': 'Barcelona', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.38879, 'lon': 2.15899}}, {'zip': '08500', 'city': 'Barcelona', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.38879, 'lon': 2.15899}}, {'zip': '08540', 'city': 'Barcelona', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.38879, 'lon': 2.15899}}, {'zip': '08907', 'city': 'Barcelona', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.38879, 'lon': 2.15899}}, {'zip': '8025', 'city': 'Barcelona', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.38879, 'lon': 2.15899}}, {'zip': '28006', 'city': 'Madrid', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.4165, 'lon': -3.70256}}, {'zip': '28007', 'city': 'Madrid', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.4165, 'lon': -3.70256}}, {'zip': '28041', 'city': 'Madrid', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.4165, 'lon': -3.70256}}, {'zip': '28046', 'city': 'Madrid', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.4165, 'lon': -3.70256}}, {'zip': '28222', 'city': 'Madrid', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.4165, 'lon': -3.70256}}, {'zip': '15706', 'city': 'Santiago de Compostela', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 42.88052, 'lon': -8.54569}}, {'zip': '46020', 'city': 'Valencia', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 39.47391, 'lon': -0.37966}}, {'zip': 'CH63 9JP', 'city': 'Bebington', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 53.35, 'lon': -3.01667}}, {'zip': 'BT2 8BG', 'city': 'Belfast', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 54.59682, 'lon': -5.92541}}, {'zip': 'B15 2SQ', 'city': 'Birmingham', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.48142, 'lon': -1.89983}}, {'zip': 'BA15 1DQ', 'city': 'Bradford on Avon Wiltsh', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site'}, {'zip': 'CF15 9SS', 'city': 'Cardiff', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.48, 'lon': -3.18}}, {'zip': 'NN17 2UR', 'city': 'Corby', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.49637, 'lon': -0.68939}}, {'zip': 'OX29 4QB', 'city': 'Eynsham', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.78077, 'lon': -1.37454}}, {'zip': 'ML4 3NJ', 'city': 'Glasgow', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 55.86515, 'lon': -4.25763}}, {'zip': 'NE46 1QJ', 'city': 'Hexham', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 54.96986, 'lon': -2.104}}, {'zip': 'PR7 7NA', 'city': 'Lancashire', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site'}, {'zip': 'L22 0LG', 'city': 'Liverpool', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 53.41058, 'lon': -2.97794}}, {'zip': 'M15 6SE', 'city': 'Manchester', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 53.48095, 'lon': -2.23743}}, {'zip': 'BR5 3QG', 'city': 'Orpington', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.37457, 'lon': 0.09785}}, {'zip': 'OX4 1XB', 'city': 'Oxford', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.75222, 'lon': -1.25596}}, {'zip': 'PE8 6PL', 'city': 'Peterborough', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.57364, 'lon': -0.24777}}, {'zip': 'CV32 4RA', 'city': 'Royal Leamington Spa', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.2852, 'lon': -1.52}}, {'zip': 'IP24 1JD', 'city': 'Thetford', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.41667, 'lon': 0.75}}, {'zip': 'OX28 6JS', 'city': 'Witney', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.7836, 'lon': -1.4854}}]}, 'ipdSharingStatementModule': {'url': 'https://www.gsk-studyregister.com/About_GSK_Patient_Level_Data_Sharing_Final_13July2023.pdf.', 'infoTypes': ['STUDY_PROTOCOL', 'SAP', 'ICF', 'CSR'], 'timeFrame': 'Anonymized IPD will be made available within 6 months of publication of primary, key secondary and safety results for studies in product with approved indication(s) or terminated asset(s) across all indications.', 'ipdSharing': 'YES', 'description': 'GSK will assess requests from qualified researchers for anonymized individual patient-level data and related study documents. Data sharing is subject to certain criteria, conditions, and exceptions. For further information, refer to https://www.gsk-studyregister.com/About\\_GSK\\_Patient\\_Level\\_Data\\_Sharing\\_Final\\_13July2023.pdf.', 'accessCriteria': 'Anonymized IPD is shared with researchers whose proposals are approved by an Independent Review Panel and after a Data Sharing Agreement is in place. Access is provided for an initial period of 12 months but an extension may be granted, when justified, for up to 6 months.'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'GlaxoSmithKline', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}